|[August 29, 2013]
Research and Markets: Overall Pre-Clinical Imaging (In Vivo) Market Valued at $790 Million in 2012, and is Estimated to Grow at an Annual Growth Rate of 14.5% Up To 2017
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/l4c22w/preclinical)
has announced the addition of the "Pre-Clinical
Imaging (In vivo) Market - By Systems and Reagents [Micro-PET, Optical
Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT &
Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global
Forecasts to 2017" report to their offering.
In 2012, North America is the biggest market, about 38.2% share of the
global pre-clinical imaging (in vivo) systems and reagents market,
followed by Europe. However, the Asian and Latin American countries
represent the fastest growing markets due to increasing government
support for research, growing number of research institution and CRO's,
and rising industry-academia partnerships for pre-clinical research.
Moreover, economic slowdown, pricing pressures and high competition in
mature countries will compel the companies to focus on the Asian market.
Pre-clinical imaging technologies are excellent tools for assessment of
anatomical, physiological and functional parametrs at molecular and
cellular levels in the live animal models. It plays a significant role
in the assessment of specific drug candidate or treatment regime, in
phenotyping and understanding the pathophysiology of various diseases.
The global pre-clinical imaging (in vivo) market has witnessed
challenging and dynamic market conditions in terms of government
funding/grants and technological advancements in the last five years.
The overall pre-clinical imaging (in vivo) market is valued at $790
million in 2012, and is estimated to grow at an annual growth rate of
14.5% over the next five years. Market displays growing preference for
new technologies such as hybrid systems - PET + MRI, SPECT + MRI and PET
+ SPECT + CT, for the continuum of advantages offered by them over
traditional standalone techniques as they enable to overcome limitations
of each technology. Pre-clinical imaging (in vivo) industry has
witnessed myriad technological advancements over the last two decades
and it is expected that this trend will continue in future to solve the
present challenges and fill the unmet needs of the market.
Pre-clinical imaging market is highly competitive, with each player
vying to make a mark and gain a large market share. Rapid industry
consolidation is a burning issue in the market currently, which not only
affects the small market players but also enforces big players to
redefine their marketing strategies.
- Aspect (News - Alert) Imaging (Israel)
- Bruker Corporation (U.S.)
- FUJIFILM Holdings Corporation (Japan)
- Gamma Medica (U.S.)
- Life Technologies Corporation (U.S.)
- Mediso Medical Imaging Systems (News - Alert) (Hungary)
- Miltenyi Biotec GmbH (Germany)
- Scanco Medical (Switzerland)
- Siemens (News - Alert) AG (Germany)
For more information visit http://www.researchandmarkets.com/research/l4c22w/preclinical
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]